{"id":514896,"date":"2021-07-20T07:08:07","date_gmt":"2021-07-20T11:08:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/"},"modified":"2021-07-20T07:08:07","modified_gmt":"2021-07-20T11:08:07","slug":"sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/","title":{"rendered":"Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on\u00a0August 4th, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NESS ZIONA, Israel, July  20, 2021  (GLOBE NEWSWIRE) &#8212; Sol-Gel Technologies, Ltd. (Nasdaq: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, will report second quarter 2021 financial results on Wednesday, August 4, 2021 at 7:05 AM ET.<\/p>\n<p>\n        <strong>About\u00a0Sol-Gel Technologies\u00a0<\/strong>\n      <\/p>\n<p>Sol-Gel\u00a0is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.\u00a0Sol-Gel\u00a0leverages its proprietary microencapsulation technology platform for the development of TWYNEO<sup>\u00ae<\/sup> under investigation for the treatment of acne vulgaris with an NDA filed with the FDA and a PDUFA goal date set for\u00a0August 1, 2021; and EPSOLAY<sup>\u00ae<\/sup>, under investigation for the treatment of inflammatory lesions of rosacea with an NDA filed with the FDA and a PDUFA goal date set for\u00a0April 26, 2021. Both product candidates are exclusively licensed for\u00a0U.S.\u00a0commercialization with\u00a0Galderma Holding SA.\u00a0\u00a0\u00a0 Action on the NDA for EPSOLAY has not yet been taken due to the inability of the FDA to conduct a pre-approval inspection of the production site of EPSOLAY as a result of COVID-19 travel restrictions. The Company\u2019s pipeline also includes SGT-210, an early-stage topical epidermal growth factor receptor inhibitor, erlotinib, under investigation for the treatment of\u00a0palmoplantar keratoderma, and preclinical assets tapinarof and roflumilast. For additional information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=T84qYd-juFVVoSM4bM5etCmgAEX0vGrmu6zALR3eeBQopvZ67fIO9yqEo4kwx33Jj6BeilOWZ3d5vvhjrdzP0w==\" rel=\"nofollow noopener\" target=\"_blank\">www.sol-gel.com<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>Irina Koffler<br \/>Investor relations,\u00a0LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=duKv4suacBvCyUnjNd47iZixrmwrj_AhsgXDM55Pz4sSYJdr1s3egXK4PO4DG16aHbpxVMeeGLlHoUN8mrqW0J3RXan383g5DKdY1TmTcmG48JACqiH5uSNaF6oTUsgI\" rel=\"nofollow noopener\" target=\"_blank\">ikoffler@lifesciadvisors.com<\/a><br \/>+1 917 734 7387<\/p>\n<p>\n        <strong>Sol-Gel Technologies<\/strong><br \/>\n        <br \/>Gilad Mamlok<br \/>Chief Financial Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JgAEHEwMYTT7katW-ZNOPpgk74YfSRq-fjfCQz0ILQwOxfSFESf7bTbmYFxTiy1NokzAEaTw5Dt2mV_Y8-BCh_Ugyj6Q9TKiEYXX6jq794U=\" rel=\"nofollow noopener\" target=\"_blank\">gilad.mamlok@sol-gel.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MjczNyM0MzAzNjU1IzIwODk2NTc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/0dbfe41d-adb7-4864-9650-2f6ed9a00c7c\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NESS ZIONA, Israel, July 20, 2021 (GLOBE NEWSWIRE) &#8212; Sol-Gel Technologies, Ltd. (Nasdaq: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, will report second quarter 2021 financial results on Wednesday, August 4, 2021 at 7:05 AM ET. About\u00a0Sol-Gel Technologies\u00a0 Sol-Gel\u00a0is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.\u00a0Sol-Gel\u00a0leverages its proprietary microencapsulation technology platform for the development of TWYNEO\u00ae under investigation for the treatment of acne vulgaris with an NDA filed with the FDA and a PDUFA goal date set for\u00a0August 1, 2021; and EPSOLAY\u00ae, under investigation for the treatment of inflammatory &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on\u00a0August 4th, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-514896","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on\u00a0August 4th, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on\u00a0August 4th, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NESS ZIONA, Israel, July 20, 2021 (GLOBE NEWSWIRE) &#8212; Sol-Gel Technologies, Ltd. (Nasdaq: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, will report second quarter 2021 financial results on Wednesday, August 4, 2021 at 7:05 AM ET. About\u00a0Sol-Gel Technologies\u00a0 Sol-Gel\u00a0is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.\u00a0Sol-Gel\u00a0leverages its proprietary microencapsulation technology platform for the development of TWYNEO\u00ae under investigation for the treatment of acne vulgaris with an NDA filed with the FDA and a PDUFA goal date set for\u00a0August 1, 2021; and EPSOLAY\u00ae, under investigation for the treatment of inflammatory &hellip; Continue reading &quot;Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on\u00a0August 4th, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-20T11:08:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MjczNyM0MzAzNjU1IzIwODk2NTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on\u00a0August 4th, 2021\",\"datePublished\":\"2021-07-20T11:08:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\\\/\"},\"wordCount\":253,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4MjczNyM0MzAzNjU1IzIwODk2NTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\\\/\",\"name\":\"Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on\u00a0August 4th, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4MjczNyM0MzAzNjU1IzIwODk2NTc=\",\"datePublished\":\"2021-07-20T11:08:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4MjczNyM0MzAzNjU1IzIwODk2NTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4MjczNyM0MzAzNjU1IzIwODk2NTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on\u00a0August 4th, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on\u00a0August 4th, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/","og_locale":"en_US","og_type":"article","og_title":"Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on\u00a0August 4th, 2021 - Market Newsdesk","og_description":"NESS ZIONA, Israel, July 20, 2021 (GLOBE NEWSWIRE) &#8212; Sol-Gel Technologies, Ltd. (Nasdaq: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, will report second quarter 2021 financial results on Wednesday, August 4, 2021 at 7:05 AM ET. About\u00a0Sol-Gel Technologies\u00a0 Sol-Gel\u00a0is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.\u00a0Sol-Gel\u00a0leverages its proprietary microencapsulation technology platform for the development of TWYNEO\u00ae under investigation for the treatment of acne vulgaris with an NDA filed with the FDA and a PDUFA goal date set for\u00a0August 1, 2021; and EPSOLAY\u00ae, under investigation for the treatment of inflammatory &hellip; Continue reading \"Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on\u00a0August 4th, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-20T11:08:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MjczNyM0MzAzNjU1IzIwODk2NTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on\u00a0August 4th, 2021","datePublished":"2021-07-20T11:08:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/"},"wordCount":253,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MjczNyM0MzAzNjU1IzIwODk2NTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/","name":"Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on\u00a0August 4th, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MjczNyM0MzAzNjU1IzIwODk2NTc=","datePublished":"2021-07-20T11:08:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MjczNyM0MzAzNjU1IzIwODk2NTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MjczNyM0MzAzNjU1IzIwODk2NTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sol-gel-technologies-to-report-second-quarter-2021-financial-results-on-august-4th-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on\u00a0August 4th, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/514896","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=514896"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/514896\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=514896"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=514896"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=514896"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}